SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE CRYPTO is gaining traction with its new listing on MEXC Meme+, energizing its dedicated "Grok's AI dog" community who are actively discussing its strong fundamentals and unique origin story as a leading AI meme coin.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN) crypto is trending due to pervasive community skepticism and accusations of it being a scam, drawing direct parallels to the controversial Mullen Automotive stock's history of significant investor losses and numerous reverse splits. While a small segment anticipates a 'run,' the dominant discussion focuses on warnings against this new token, citing the stock's past as a 'rug pull.'

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending amid resurfacing acquisition rumors, with French publication La Lettre reporting a potential $176-per-share offer from AstraZeneca following earlier Eli Lilly bid speculation. The community is actively discussing the differentiated profile of obefazimod for inflammatory bowel disease and the high buyout premium the company could command.

SharonAI Holdings, Inc. is a technology company. It focuses on high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI Holdings (SHAZ) is surging amidst community discussion following the release of an ambitious long-term roadmap outlining significant capacity expansion into 2028, further fueled by its association with the bullish AI sector and a notable photo of its co-founder with NVIDIA's CEO.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as a flurry of speculative interest, including mentions of activity on pump platforms, draws attention to the crypto's unique move-to-earn model, where users earn tokens for physical activity. The community is actively debating its long-term potential, with some seeing value in its health-incentivizing utility despite its current low market valuation.

Tidal Trust II - Defiance Nasdaq 100 Weekly Distribution ETF

Defiance Nasdaq 100 Target 30 Income ETF

QQQY is a key focus as investors evaluate its consistent weekly dividend distributions, actively weighing the high income generation against persistent concerns about NAV erosion and overall total return. The community is debating how the fund's 0DTE options strategy and recent shift to weekly payouts are impacting its ability to balance yield with capital preservation.

Cogent Communications Holdings, Inc. engages in the provision of Internet access and Internet Protocol (IP) communications solutions. It offers Internet access and data transport through its fiber optic, IP data-only network, ethernet transport, and colocation services. The company was founded by David Schaeffer in August 1999 and is headquartered in Washington, DC.

Cogent Communications Holdings Inc

Cogent Communications is trending after a substantial dividend cut and widespread community frustration regarding management's communication on its highly leveraged balance sheet, exacerbated by recent CEO share sales; however, some investors are eyeing a potential turnaround driven by growth in AI wavelength revenue and anticipated data center asset divestitures.

Sensata Technologies Holding Plc is a global industrial technology company, which engages in the development, manufacture, and sale of sensors and sensor-rich solutions, electrical protection components and systems, and other products used in mission-critical systems and applications. The firm operates through the Performance Sensing and Sensing Solutions segments. The Performance Sensing segment serves the automotive and heavy vehicle and off-road (HVOR) industries through the development and manufacture of sensors, high-voltage solutions, and other solutions used in mission-critical systems and applications. The Sensing Solutions segment engages in the industrial and aerospace industries through the development and manufacture of a portfolio of application-specific sensor and electrical protection products used in industrial markets, including the appliance, heating, ventilation, and air conditioning (HVAC), water management, operator controls, charging infrastructure, renewable energy generation, green hydrogen production, and microgrid applications and markets, as well as the aerospace market, including commercial aircraft, defense, and aftermarket markets. The company was founded by Rathbun Willard in 1916 and is headquartered in Attleboro, MA.

Sensata Technologies Holding Plc

Sensata Technologies (ST) is trending after a mixed reaction to its recent Q4 earnings beat, as shares pulled back despite solid results and several analyst price target raises. The community is actively debating if this dip is a buying opportunity, with many also focusing on the company's strategic advancements in high-voltage EV solutions as a significant long-term catalyst.

Vishay Precision Group, Inc. engages in the provision of precision measurement and sensing technologies. The firm serves a diverse array of industries and markets, including industrial, test and measurement, transportation, steel, medical, agriculture, avionics, military and space, and consumer. It operates through the following segments: Sensors, Weighing Solutions, Measurement Systems, and Corporate and Other. The Sensors segment is composed of the foil resistor and strain gage operating divisions. The Weighing Solutions segment consists of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment includes specialized systems for steel production, materials development, and safety testing. The company was founded on August 28, 2009 and is headquartered in Malvern, PA.

Vishay Precision Group Inc

Vishay Precision Group (VPG) is trending following its Q4 earnings, which showcased exceptional growth in its humanoid and strategic initiatives segment, amplifying community speculation about its critical role as a precision sensor supplier for advanced humanoid robots like Tesla's Optimus and Figure AI.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following robust Phase 2 axSpA clinical trial results for sonelokimab, described by the community as potentially "best-in-class" and generating significant buzz ahead of its Investor Day, amplifying discussions around substantial short interest and potential major acquisition interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TCR2 is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep understanding of T cell receptor biology enabled the creation of a novel first-in-class approach that is highly differentiated from CAR-T cells and from T cells engineered to express defined TCR alpha/beta chains. TCR2 was founded by Dr. Patrick Baeuerle and MPM Capital. It has scientific operations in Kendall Square, Cambridge, Massachusetts to leverage best-in-class technologies and nucleate top-tier academic laboratories around the world.

TCRR
Tcr2 Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TCRR News

TCRRTcr2 Therapeutics Inc